Skip to main content
Back to companies
Edgewise Therapeutics logo

Edgewise Therapeutics

Biotech/PharmaBiopharmaBiotechnologyHealth Care
Boulder, Colorado, United StatesFounded 2017114+ employeesEWTX
$738.5M raisedIPO· last: post ipo equity (Apr 2025)· 6 rounds
Backed by(26 investors)
Novo Holdings · LeadU.S. Venture Partners · LeadViking Global Investors · Lead+13 more

Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions.

Founders

Skip jobs list

Open Positions at Edgewise Therapeutics (0 Jobs)

No open positions at the moment.
Try adjusting your filters or browse all jobs
Browse All Jobs